Bioavailability Study of Valganciclovir Hydrochloride Tablets 450 mg Under Fasting Condition
Status:
Completed
Trial end date:
2011-08-01
Target enrollment:
Participant gender:
Summary
This study is to assess the Valganciclovir Hydrochloride Tablets 450 mg of Dr. Reddy's
Laboratories Limited, India and Valcyte® (Valganciclovir HCl) tablets 450 mg of Genentech USA
Inc., Group of Roche, South San Francisco in healthy, adult, human subjects under Fasting
conditions.